Literature DB >> 21059868

Mammalian polycomb-like Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate polycomb activity both at the Hox gene cluster and at Cdkn2a genes.

Xiangzhi Li1, Kyo-Ichi Isono, Daisuke Yamada, Takaho A Endo, Mitsuhiro Endoh, Jun Shinga, Yoko Mizutani-Koseki, Arie P Otte, Miguel Casanova, Hiroshi Kitamura, Takehiko Kamijo, Jafar Sharif, Osamu Ohara, Tetsuro Toyada, Bradley E Bernstein, Neil Brockdorff, Haruhiko Koseki.   

Abstract

The Polycomb group of proteins forms at least two distinct complexes designated the Polycomb repressive complex-1 (PRC1) and PRC2. These complexes cooperate to mediate transcriptional repression of their target genes, including the Hox gene cluster and the Cdkn2a genes. Mammalian Polycomb-like gene Pcl2/Mtf2 is expressed as four different isoforms, and the longest one contains a Tudor domain and two plant homeodomain (PHD) fingers. Pcl2 forms a complex with PRC2 and binds to Hox genes in a PRC2-dependent manner. We show that Pcl2 is a functional component of PRC2 and is required for PRC2-mediated Hox repression. Pcl2, however, exhibits a profound synergistic effect on PRC1-mediated Hox repression, which is not accompanied by major alterations in the local trimethylation of histone H3 at lysine 27 (H3K27me3) or PRC1 deposition. Pcl2 therefore functions in collaboration with both PRC2 and PRC1 to repress Hox gene expression during axial development. Paradoxically, in embryonic fibroblasts, Pcl2 is shown to activate the expression of Cdkn2a and promote cellular senescence, presumably by suppressing the catalytic activity of PRC2 locally. Taken together, we show that Pcl2 differentially regulates Polycomb-mediated repression of Hox and Cdkn2a genes. We therefore propose a novel role for Pcl2 to modify functional engagement of PRC2 and PRC1, which could be modulated by sensing cellular circumstances.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21059868      PMCID: PMC3019975          DOI: 10.1128/MCB.00259-10

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  66 in total

1.  Reconstitution of a functional core polycomb repressive complex.

Authors:  N J Francis; A J Saurin; Z Shao; R E Kingston
Journal:  Mol Cell       Date:  2001-09       Impact factor: 17.970

2.  Histone methyltransferase activity of a Drosophila Polycomb group repressor complex.

Authors:  Jürg Müller; Craig M Hart; Nicole J Francis; Marcus L Vargas; Aditya Sengupta; Brigitte Wild; Ellen L Miller; Michael B O'Connor; Robert E Kingston; Jeffrey A Simon
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

3.  Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites.

Authors:  Birgit Czermin; Raffaella Melfi; Donna McCabe; Volker Seitz; Axel Imhof; Vincenzo Pirrotta
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

4.  Xenopus Polycomblike 2 (XPcl2) controls anterior to posterior patterning of the neural tissue.

Authors:  T Kitaguchi; K Nakata; T Nagai; J Aruga; K Mikoshiba
Journal:  Dev Genes Evol       Date:  2001-06       Impact factor: 0.900

5.  The polycomb-group gene Ezh2 is required for early mouse development.

Authors:  D O'Carroll; S Erhardt; M Pagani; S C Barton; M A Surani; T Jenuwein
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Polycomblike PHD fingers mediate conserved interaction with enhancer of zeste protein.

Authors:  S O'Connell; L Wang; S Robert; C A Jones; R Saint; R S Jones
Journal:  J Biol Chem       Date:  2001-09-24       Impact factor: 5.157

7.  The core of the polycomb repressive complex is compositionally and functionally conserved in flies and humans.

Authors:  Stuart S Levine; Alona Weiss; Hediye Erdjument-Bromage; Zhaohui Shao; Paul Tempst; Robert E Kingston
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  Native and recombinant polycomb group complexes establish a selective block to template accessibility to repress transcription in vitro.

Authors:  Ian F G King; Nicole J Francis; Robert E Kingston
Journal:  Mol Cell Biol       Date:  2002-11       Impact factor: 4.272

9.  A panel of monoclonal antibodies against human polycomb group proteins.

Authors:  Karien M Hamer; Richard G A B Sewalt; Jan L den Blaauwen; Thijs Hendrix; David P E Satijn; Arie P Otte
Journal:  Hybrid Hybridomics       Date:  2002-08

10.  Mice doubly deficient for the Polycomb Group genes Mel18 and Bmi1 reveal synergy and requirement for maintenance but not initiation of Hox gene expression.

Authors:  T Akasaka; M van Lohuizen; N van der Lugt; Y Mizutani-Koseki; M Kanno; M Taniguchi; M Vidal; M Alkema; A Berns; H Koseki
Journal:  Development       Date:  2001-05       Impact factor: 6.868

View more
  34 in total

1.  PHF1 Tudor and N-terminal domains synergistically target partially unwrapped nucleosomes to increase DNA accessibility.

Authors:  Matthew D Gibson; Jovylyn Gatchalian; Andrew Slater; Tatiana G Kutateladze; Michael G Poirier
Journal:  Nucleic Acids Res       Date:  2017-04-20       Impact factor: 16.971

2.  miR-155 activates cytokine gene expression in Th17 cells by regulating the DNA-binding protein Jarid2 to relieve polycomb-mediated repression.

Authors:  Thelma M Escobar; Chrysi Kanellopoulou; David G Kugler; Gokhul Kilaru; Cuong K Nguyen; Vijayaraj Nagarajan; Ravikiran K Bhairavabhotla; Daniel Northrup; Rami Zahr; Patrick Burr; Xiuhuai Liu; Keji Zhao; Alan Sher; Dragana Jankovic; Jinfang Zhu; Stefan A Muljo
Journal:  Immunity       Date:  2014-05-22       Impact factor: 31.745

3.  An aromatic cage is required but not sufficient for binding of Tudor domains of the Polycomblike protein family to H3K36me3.

Authors:  Jovylyn Gatchalian; Molly C Kingsley; Stacey D Moslet; Ruben D Rosas Ospina; Tatiana G Kutateladze
Journal:  Epigenetics       Date:  2015-04-29       Impact factor: 4.528

4.  Functional Proteomic Analysis of Repressive Histone Methyltransferase Complexes Reveals ZNF518B as a G9A Regulator.

Authors:  Verena K Maier; Caitlin M Feeney; Jordan E Taylor; Amanda L Creech; Jana W Qiao; Attila Szanto; Partha P Das; Nicholas Chevrier; Catherine Cifuentes-Rojas; Stuart H Orkin; Steven A Carr; Jacob D Jaffe; Philipp Mertins; Jeannie T Lee
Journal:  Mol Cell Proteomics       Date:  2015-02-13       Impact factor: 5.911

5.  Competition between PRC2.1 and 2.2 subcomplexes regulates PRC2 chromatin occupancy in human stem cells.

Authors:  Daniel T Youmans; Anne R Gooding; Robin D Dowell; Thomas R Cech
Journal:  Mol Cell       Date:  2020-12-17       Impact factor: 17.970

Review 6.  Long non-coding RNAs: challenges for diagnosis and therapies.

Authors:  Yolanda Sánchez; Maite Huarte
Journal:  Nucleic Acid Ther       Date:  2013-02       Impact factor: 5.486

7.  Polycomblike 2 facilitates the recruitment of PRC2 Polycomb group complexes to the inactive X chromosome and to target loci in embryonic stem cells.

Authors:  Miguel Casanova; Tanja Preissner; Andrea Cerase; Raymond Poot; Daisuke Yamada; Xiangzhi Li; Ruth Appanah; Karel Bezstarosti; Jeroen Demmers; Haruhiko Koseki; Neil Brockdorff
Journal:  Development       Date:  2011-03-02       Impact factor: 6.868

8.  Polycomb PHF19 binds H3K36me3 and recruits PRC2 and demethylase NO66 to embryonic stem cell genes during differentiation.

Authors:  Gerard L Brien; Guillermo Gambero; David J O'Connell; Emilia Jerman; Siobhán A Turner; Chris M Egan; Eiseart J Dunne; Maike C Jurgens; Kieran Wynne; Lianhua Piao; Amanda J Lohan; Neil Ferguson; Xiaobing Shi; Krishna M Sinha; Brendan J Loftus; Gerard Cagney; Adrian P Bracken
Journal:  Nat Struct Mol Biol       Date:  2012-11-18       Impact factor: 15.369

Review 9.  Cellular senescence and tumor suppressor gene p16.

Authors:  Hani Rayess; Marilene B Wang; Eri S Srivatsan
Journal:  Int J Cancer       Date:  2011-12-05       Impact factor: 7.396

Review 10.  H3K27 Methylation: A Focal Point of Epigenetic Deregulation in Cancer.

Authors:  J N Nichol; D Dupéré-Richer; T Ezponda; J D Licht; W H Miller
Journal:  Adv Cancer Res       Date:  2016-06-17       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.